TP53 and pancreatitis: The results revealed the notably elevated expression of MVP in Grade 3 tumors compared to other grades, the obviously higher expression in patients with pancreatitis than those without pancreatitis or normal individuals, and the significantly upregulated expression in patients with TP53-mutant PAAD compared to those with the non-mutant type (Supplementary Figures 1A–D).